30 March - 6 April 2018
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts
NICE says no to ocrelizumab for RRMS
NICE has judged the cost of the drug for relapsing MS to be "too high to be considered an acceptable use of NHS resources", according to their draft appraisal. There is now a public consultation on the draft until 25 April. A final decision is expected in July.
MS Trust link: Ocrelizumab (Ocrevus)
Cognitive training helps memory
A computer-based course of cognitive training helped improve cognitive symptoms, particularly memory, according to a review of nine previous studies. The studies didn't specify if people with different types of MS did better than others
Source: Neurology Advisor
MS Trust link: Cognition and cognitive symptoms
Prescription charge increase
The cost of a prescription in England went up by 20p to £8.80 on 1 April. The cost of certificates (PPCs) covering all prescriptions is a three month or twelve month period remain unchanged. There are no prescription charges in Scotland, Wales and Northern Ireland.
MS Trust link: Prescription charges